- Report
- January 2022
- 122 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 111 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- February 2024
- 120 Pages
Global
From €4226EUR$4,750USD£3,649GBP
- Report
- June 2024
- 437 Pages
Global
From €3959EUR$4,450USD£3,419GBP
- Report
- November 2023
- 170 Pages
Global
From €3959EUR$4,450USD£3,419GBP
- Report
- January 2023
- 145 Pages
Europe
From €3069EUR$3,450USD£2,650GBP
- Report
- January 2023
- 161 Pages
North America
From €3069EUR$3,450USD£2,650GBP
- Report
- January 2023
- 164 Pages
Asia Pacific
From €3069EUR$3,450USD£2,650GBP
- Report
- January 2023
- 140 Pages
Middle East, Africa
From €3069EUR$3,450USD£2,650GBP
- Report
- January 2023
- 145 Pages
From €3069EUR$3,450USD£2,650GBP
- Report
- December 2022
- 206 Pages
Africa, Middle East, Turkey Africa, Middle East, Turkey
From €3069EUR$3,450USD£2,650GBP
- Report
- November 2022
- 125 Pages
From €3069EUR$3,450USD£2,650GBP
- Report
- November 2022
- 121 Pages
North America
From €3069EUR$3,450USD£2,650GBP
- Report
- November 2022
- 133 Pages
Africa, Middle East
From €3069EUR$3,450USD£2,650GBP
- Report
- November 2022
- 138 Pages
Europe
From €3069EUR$3,450USD£2,650GBP
- Report
- November 2022
- 138 Pages
Asia Pacific
From €3069EUR$3,450USD£2,650GBP
- Report
- December 2024
- 90 Pages
Indonesia
From €2028EUR$2,280USD£1,752GBP
€2536EUR$2,850USD£2,189GBP
- Report
- May 2024
- 124 Pages
Global
From €2811EUR$3,160USD£2,428GBP
€3514EUR$3,950USD£3,035GBP
- Report
- April 2024
- 134 Pages
Global
From €2811EUR$3,160USD£2,428GBP
€3514EUR$3,950USD£3,035GBP
- Report
- April 2024
- 135 Pages
Global
From €2811EUR$3,160USD£2,428GBP
€3514EUR$3,950USD£3,035GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more